PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +200.0% | 171,150 | +959.8% | 0.00% | – |
| Q2 2022 | $10,000 | -93.3% | 16,150 | -85.7% | 0.00% | -100.0% |
| Q1 2022 | $149,000 | -25.1% | 113,150 | +48.6% | 0.01% | -14.3% |
| Q4 2021 | $199,000 | -27.4% | 76,150 | -13.6% | 0.01% | -36.4% |
| Q3 2021 | $274,000 | +40.5% | 88,150 | +68.1% | 0.01% | +37.5% |
| Q2 2021 | $195,000 | – | 52,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|